Specialty Pharmacy

Oxygen therapy use spikes since 2000.

Pharmacy expenditures account for 20% of total care costs for children with hemophilia.

Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses whether the R&D cost for biosimilars will affect the overall cost reduction.

Studies show inexpensive, generic drugs can help reduce breast cancer mortality in postmenopausal women.

Elevated risk found for heart arrhythmia, specifically atrial fibrillation.

Top stories of the week on Specialty Pharmacy Times.

Compound shows promise in reducing a precursor to RA.

Lithium chloride found to slow degradation.

Algorithm uses a computational model of the human body's protein networks.

Up to 13% of patients considered to have chronic obstructive pulmonary disease (COPD) under current criteria were recently found to be misdiagnosed.

The FDA has granted priority review to Merck's chronic hepatitis C virus (HCV) treatment candidate grazoprevir/elbasvir.

Liver damage progresses at a more rapid pace in patients with HIV.

Long-term survival results after 5 years of ipilimumab therapy in patients with advanced melanoma shows promise.

Researchers evaluate solutions to quality-of-life issues.

Galena Biopharma had introduced ondansetron (Zuplenz) to the US market.

Sofosbuvir-based therapy offers the potential for high cure rates even in difficult-to-treat patient groups.

Toradol may limit ability of tumor cells to grow and spread.

Toxin may inhibit cell division in cancerous cells.

Generic Pulmicort Respules is approved for the treatment of asthma and to serve as prophylactic therapy in children aged 12 months to 8 years.

Study finds 80% of people with cardiovascular disease significantly underuse statins.

Results of the long-awaited Keynote 006 study prove the superiority of pembrolizumab to ipilimumab on criteria of both progression-free survival and overall survival.

Destabilized cell metabolism can lead to the creation of tumors.

Teva has voluntarily recalled 6 lots of fluorouracil (Adrucil) injection due to contamination.

Only 1 in 3 older adults with diabetes meet the American Diabetes Association's treatment targets for blood glucose, cholesterol, and blood pressure.

Iressa blocks the activity of an enzyme responsible for regulating pathways implicated in the growth and survival of cancer cells.

Heat shock protein inhibitors may stop proteins involved in cancer cell survival.

Amino acid abundant in meat and fish could open receptors in cancer cells.

A pharmacy in Washington is recalling unexpired human and veterinary compounded drugs due to concerns about their sterility.